BNB, Binance’s native cryptocurrency token, jumped to a new all-time high of more than $880 on Wednesday, August 20. This was despite its major treasury adopter, Windtree Therapeutics, announcing that it will be delisted by Nasdaq Capital Market.
Windtree Therapeutics, a Pennsylvania-based biopharmaceutical company focused on respiratory and cardiovascular treatments, filed with the U.S. Securities and Exchange Commission (SEC) on August 20, confirming that Nasdaq will suspend trading of its stock on August 21.
The delisting comes after the company failed to maintain the minimum bid price of $1 per share for 30 consecutive business days, as required by Listing Rule 5550(a)(2). The company will move its shares, ticker WINT, to over-the-counter (OTC) markets, which have lower liquidity and less transparency than Nasdaq.
Windtree said the transition will not affect its business operations but noted that approval for its OTC Integrated Disclosure (OTCID) tier listing is not guaranteed. WINT shares plunged 77% following the announcement.
This failure comes after Windtree announced its BNB treasury strategy, launched in late July 2025, raising up to $520 million, with 99% of the funds used to purchase BNB.
Despite the negative news, BNB climbed 5% in 24 hours, according to CoinMarketCap data, bouncing off its 14-day Exponential Moving Average (EMA) near $814 support.
Analysts Predict Further Gains for BNB
According to analysts, the token may touch a high of $900 in the next few days. If the market turns bearish or momentum fades, a sharp pullback toward the $700 zone for a retest is likely. The Relative Strength Index (RSI) and Stochastic Oscillator (Stoch) are also showing that BNB is approaching the overbought zone.
The rally of BNB indicates an increase in investor confidence in crypto assets, despite the volatility in companies pursuing crypto treasury policies.
Also Read: CEA Industries Becomes Largest BNB Holder After $160M Buy
